Anuh Pharma Reports Strong Q2 FY27 Profit Growth Driven by Margin Expansion
Anuh Pharma Ltd 路 Financial Result 路 30 Oct 2026, 10:48 pm
Anuh Pharma Reports Strong Q2 FY27 Profit Growth Driven by Margin Expansion Anuh Pharma reported Q2 FY27 revenue from operations of Rs 18,524.14 lakhs, remaining flat YoY (Rs 18,588.27 lakhs in Q2 FY26) and down 4.4% QoQ. Net profit rose 47.3% YoY to Rs 1,121.31 lakhs from Rs 761.25 lakhs, while dipping 1.9% QoQ. EBITDA jumped 36.5% YoY to Rs 1,755.13 lakhs, expanding margins by 255 bps YoY to 9.47%. H1 FY27 PAT grew 42.3% YoY to Rs 2,263.80 lakhs. Operating cash flow improved significantly to positive Rs 2,668.23 lakhs for H1 FY27.
Original exchange filing (PDF)
More announcements from Anuh Pharma Ltd
- Capacity Addition by inauguration of the F-10/1, M.I.D.C., Tarapur, Boisar, District Palghar - 401506, Maharashtra, India. 路 16 Nov 2026
- This is to inform that the Company has inaugurated its new manufacturing facility situated at F-10/1, M.I.D.C., Tarapur, Boisar, District Palghar - 401506, Maharashtra, India. 路 16 Nov 2026
- Investor Presentation for Q2 and H1 FY 2026-27 路 06 Nov 2026
- Request received for withdrawal of application for reclassification of shareholding from "Promoter & Promoter Group" to "Public Category". 路 30 Oct 2026
- Anuh Pharma Limited has informed the Exchange regarding 'Financial Results'. 路 30 Oct 2026
- To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter and half year ended 30th September, 2026 and Request received for withdrawal .... 路 30 Oct 2026
- Anuh Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 30 Oct 2026
- ANUH PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 30-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 30 Oct 2026
